University of Oxford
University Offices
Wellington Square
Oxford
England
OX1 2JD
United Kingdom
Website: http://www.ox.ac.uk/index.html
242 articles about University of Oxford
-
New partnership aims to advance vaccine against MERS coronavirus
12/21/2023
Barinthus Biotherapeutics plc, formerly Vaccitech plc, announced a project with the Coalition for Epidemic Preparedness Innovations and the University of Oxford, aiming to fast-track the development of a vaccine candidate known as VTP-500 for the prevention of Middle East Respiratory Syndrome, the often fatal disease caused by the MERS coronavirus.
-
Clario's Precision Motion Opal® technology powers University of Oxford breakthrough in Parkinson's Disease
10/27/2023
Clario today announced that the application of Opal® wearable sensor technology (legacy APDM, Inc.), with advisory from Precision Motion scientists, has helped the University of Oxford researchers develop a new understanding of motor symptom progression in Parkinson's Disease, offering promising implications for neuroscience clinical trials and future treatments.
-
The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson's Disease
6/5/2023
The University of Oxford and Selvita, one of the largest contract research organizations in Europe, announced an integrated drug discovery collaboration in the area of Parkinson's disease.
-
The week has seen a series of significant updates from BioVie, Regeneron, Relay Therapeutics, Oxford University, Vistagen and Palatin.
-
Research Roundup: New Target for Crohn's, Myocarditis and COVID-19 and a Neuroblastoma Breakthrough
8/26/2022
This week's research roundup includes studies involving Crohn's disease, myocarditis, COVID-19, a potential cure for childhood brain tumors and more. -
In an interview with Reuters, AstraZeneca CEO Pascal Soriot said Tuesday that he isn't sure if the company will continue developing vaccines. He also hinted at potential M&A action.
-
Metabolon Partners with the University of Oxford Parkinson's Disease Centre
8/23/2022
Metabolon, Inc. announced it is partnering with the University of Oxford Parkinson's Disease Centre to identify metabolomic biomarkers related to Parkinson's disease progression and prediction and to detect new therapeutic targets.
-
A fat hormone that slows liver tumor growth, a genetic map to track tumorigenesis, study that shows we inherit more than expected epigenetic information from our mothers, Alzheimer linked APOE gene protects against glaucoma.
-
Scientists from the University of Edinburgh have shown that Terazosin approved for high blood pressure and prostate enlargement could be repurposed for another unlikely indication: ALS.
-
Researchers have found that two common viruses—the varicella zoster and herpes simplex viruses—likely constitute a pathway that leads to Alzheimer's disease.
-
Covid-19, aging, stroke, ALS, colorectal cancers and Alzheimer's disease are all the focus of this week's top research stories.
-
Auron Therapeutics reels in $48 million to identify novel AI-based cancer targets, Frontera scoops up $160 million for AAV gene therapy and tech manufacturing and MMI scores $75 million for robotic microsurgery.
-
A recent study published in Nature Medicine found that people who were vaccinated had a slightly decreased risk of getting Long COVID six months after their initial diagnosis.
-
Elysium Health™ Announces New Research Initiative in Partnership With the University of Oxford in Connection With the Landmark INTERBIO-21st Study
4/6/2022
Elysium Health, Inc. has entered into a material transfer agreement with the University of Oxford to analyze the DNA methylation patterns of 2,500 umbilical cord blood samples from the landmark INTERBIO-21st Study.
-
Elysium Health™ Announces Research Partnership with the University of Oxford for the Purpose of Developing Epigenetic Measures of Brain Aging and Health
3/23/2022
Elysium Health, Inc.™, a leading life sciences company focused on aging research, has entered into a material transfer agreement with the University of Oxford to examine hundreds of samples from the VITACOG study to develop epigenetic measures of brain aging and health.
-
Sir Mene Pangalos said the company was considering not submitting it to the FDA if it finds it is “banging its head against a brick wall indefinitely.”
-
After reviewing the trial’s Independent Data Monitoring Committee, the EMPA-KIDNEY trial announced it would stop early as it met prespecified criteria for positive efficacy.
-
Public health officials begin to think we’ve turned the corner on the pandemic as new global cases drop 21% last week, the third consecutive week numbers and deaths have declined.
-
With the Omicron surge waning, at least in the U.S., there is speculation that the COVID-19 pandemic may be in its end stages. Some experts, however, warn that this could be premature.
-
Oxford Professor: Tarnished AstraZeneca Vaccine Rep Probably "Killed Hundreds of Thousands"
2/10/2022
As AstraZeneca released its 2021 annual financial report, a BBC documentary suggested that the way scientists and politicians politicized its COVID-19 vaccine may have cost lives.